Skip to search formSkip to main contentSkip to account menu

ABT 341

Known as: ABT-341, ABT341 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Biphenyl CompoundsDipeptidyl-Peptidase IV InhibitorsTriazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341…
PURPOSE The purpose of this exercise was to explore the utility of allometric scaling approach for the prediction of intravenous… 
Highly Cited
2011
Highly Cited
2011
One-pot high-yielding synthesis of the DPP4-selective inhibitor ABT-341 by a four-component coupling mediated by a diphenylprolinol silyl ether.
2006
2006
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective…
Dipeptidyl peptidase IV (DPP4) deactivates glucose-regulating hormones such as GLP-1 and GIP, thus, DPP4 inhibition has become a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)